Melanoma Clinical Trials in Salt Lake City

Showing 121-136 of 136 trials

Vaccine Therapy in Treating Patients With Malignant Melanoma

NCT00128583

RATIONALE: Vaccines made from tumor cells may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase II trial is studying vaccine therapy to see how well it works in treating patients with malignant melanoma.

Melanoma (Skin)

CancerVax CorporationStarted Jul 2005

Palm Springs, California, United States • Santa Monica, California, United States • Lakeland, Florida, United States +8 more locations

COMPLETEDPHASE2< 1 mile

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

NCT00026520

RATIONALE: Interferon alfa may interfere with the growth of cancer cells and slow the growth of the tumor. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. Combining interferon alfa with thalidomide may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining interferon alfa with thalidomide in treating patients who have stage IV melanoma.

Melanoma (Skin)

SWOG Cancer Research NetworkStarted Nov 2001

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +91 more locations

Vaccine Therapy in Treating Patients With Malignant Melanoma

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Melanoma Trials in Other Cities

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Study of CP-675,206 in Refractory Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Vaccine Therapy for Patients With Stage IV Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

A Study of Volociximab in Metastatic Melanoma

Study of XL281 in Adults With Solid Tumors

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

CP-675,206 In Patients With Advanced Melanoma

Other Conditions in Salt Lake City